Nuvectis Pharma, Inc. NVCT Business Segments — Manufacturing Costs
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Nuvectis Pharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ManufacturingCosts.
The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvectis Pharma, Inc.'s business segments — manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvectis Pharma, Inc.'s business segments — manufacturing costs?
- Nuvectis Pharma, Inc. (NVCT) reported business segments — manufacturing costs of $829K in Q1 2026.
- How has Nuvectis Pharma, Inc.'s business segments — manufacturing costs changed year-over-year?
- Nuvectis Pharma, Inc.'s business segments — manufacturing costs increased by 74.2% year-over-year, from $476K to $829K.
- What is the long-term trend for Nuvectis Pharma, Inc.'s business segments — manufacturing costs?
- Over 2 years (2023 to 2025), Nuvectis Pharma, Inc.'s business segments — manufacturing costs has grown at a -21.9% compound annual growth rate (CAGR), from $3.5M to $2.13M.
- What does business segments — manufacturing costs mean?
- Expenditures related to the production of drug candidates, including raw materials, contract manufacturing organization fees, and quality control. These costs are essential for scaling the supply of therapeutic agents for clinical use.